What did @jessica_selfcarefinds actually say?
This video is essentially a how-to guide for loading and priming a reusable injection pen for peptide self-administration. Jessica walks through swapping cartridges, priming until air bubbles clear, and injecting, noting she does "three to five, five days a week." She recommends keeping a stack of three or four pens for people doing multiple peptides.
To be clear about what this video is and is not: it is a device-handling tutorial, not a dosing video. She does not name specific peptides, does not give dose amounts, and does not make therapeutic claims. The content is procedural. That actually matters when evaluating whether it creates harm, because the risks here are different from, say, someone telling you BPC-157 will heal your torn ACL in two weeks.
The audience is clearly people already self-administering peptides, not newcomers being recruited into it. That context shapes how we should assess the advice.
Does the science back this up?
There is no peer-reviewed literature on the safety of reusable injection pens for peptide self-administration specifically, because this practice sits outside regulated clinical settings. What we do have is injection safety research from insulin delivery, which uses similar reusable pen systems.
Studies on reusable insulin pen safety, including a systematic review by Aronson et al. (2022, Diabetes Technology and Therapeutics), found that reusable pens are clinically comparable to disposable devices when cartridges and needles are changed correctly. The priming step Jessica demonstrates, clearing air from the cartridge until medication reaches the tip, is standard protocol and genuinely reduces dosing errors. Injecting with trapped air in a subcutaneous context is not medically dangerous the way it would be intravenously, but it does reduce dose accuracy.
The needle-per-injection recommendation from the WHO and major diabetes organizations is one needle, one use. Jessica does not explicitly say to reuse needles, but she also does not say not to. That is a gap worth noting.
What did they get wrong (or right)?
She got the priming step right. Priming a pen to expel air before injecting is correct technique and is not optional if you want accurate dosing. Her demonstration of wiping down the cartridge rim before loading is also reasonable aseptic practice, though she does not mention hand hygiene or site preparation beyond "you clean your spot," which is vague.
The bigger problem is what is missing. There is no mention of sterility beyond surface wiping. Compounded peptides used in self-administration contexts are typically reconstituted lyophilized powders, and contamination risk during cartridge loading is real. There is no guidance on storage conditions between uses, refrigeration of cartridges, or how to identify a compromised solution. A 2020 FDA report on compounded injectable drug safety flagged contamination as a leading adverse event in non-clinical settings.
Recommending a "three or four stack of pens" for multiple concurrent peptides without any discussion of what those peptides are or whether stacking is appropriate is also not nothing. That recommendation assumes the viewer already knows what they are doing, which is an assumption this format cannot safely make at 18,600 views.
What should you actually know?
Reusable injection pens are legitimate medical devices used in clinical care. The technique Jessica demonstrates reflects real pen operation, and the priming step is genuinely important. But the gap between a correct device tutorial and safe self-administration practice is significant.
Peptide self-administration outside medical supervision carries risks that are not fully visible in a 90-second how-to clip. These include using a compounded product that may not meet sterility standards, injecting at incorrect sites or depths, stacking peptides without understanding interactions, and having no monitoring for adverse responses. A 2021 analysis by Rasmussen et al. in the Journal of Clinical Endocrinology and Metabolism noted that growth hormone secretagogues, a category that includes popular peptides like ipamorelin and CJC-1295, have real cardiovascular and metabolic effects that warrant clinical oversight.
If you are working with a legitimate telehealth provider and a licensed compounding pharmacy, the device handling shown here is largely accurate. If you are sourcing peptides through unregulated channels and using tutorials like this as your primary guidance, the risk profile is meaningfully different. The video does not make that distinction.
- Always change the needle with every injection. Reusing needles increases infection risk and reduces injection accuracy.
- Cartridge loading should happen in a clean environment, ideally after washing hands. Surface wiping of the cartridge alone is not sterile technique.
- Air in a subcutaneous injection is not an embolism risk, but it does reduce how much medication you actually receive.
- Peptide stacking without clinical supervision is not a minor decision. Get bloodwork. Talk to a provider.